NEOJECT 200 ANTIBIOTIC INJECTION
国: オーストラリア
言語: 英語
ソース: APVMA (Australian Pesticides and Veterinary Medicines Authority)
情報リーフレット 有効成分:
NEOMYCIN SULFATE
から入手可能:
CEVA ANIMAL HEALTH PTY LTD
INN（国際名）:
neomycin sulfate(200mg/mL)
医薬品形態:
PARENTERAL LIQUID/SOLUTION/SUSPENSION
構図:
NEOMYCIN SULFATE ANTIBIOTIC Active 200.0 mg/ml
パッケージ内のユニット:
100mL; Unit = 1mL
クラス:
VM - Veterinary Medicine
製:
CEVA ANIMAL HEALTH
治療群:
CAT | CATTLE | DOG | HORSE | PIGS | SHEEP | BEEF | BITCH | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK |
治療領域:
ANTIBIOTIC & RELATED
適応症:
ANTIBIOTICS - ORAL, PARENTERAL | AIRSACCULITIS | AMOXYCILLIN SENSITIVE BACTERIA | ANAEROBIC BACTERIAL INFECTION | AVIAN MYCOPLASMAS | CLAVULANIC ACID SENSITIVE | COCCIDIOSIS | CORYZA | CRD | DERMATOSES | DIARRHOEA | ENDOMETRITIS | ENTERITIS | ENZOOTIC PNEUMONIA | ESCHERICHIA COLI | EUROPEAN BROOD DISEASE | GENTAMICIN SENSITIVE | HYPERMOTILITY | INFECTED WOUNDS | INFECTIONS | LACTATING | MASTITIS | PROTOZOAL INFECTIONS | PYOMETRA | SALMONELLOSIS | SINUSITIS | SYSTEMIC BACTERIAL INFECTION
製品概要:
Poison schedule: 4; Withholding period: WHP: MEAT: DO NOT ADMINISTER LATER THAN 30 DAYS CATTLE SHEEP PIGS AND HORSES BEFORE SLAUGHTER FOR HUMAN CONSUMPTION . MILK: MILK TAKEN FROM ANIMALS WITHIN 36 HOURS SINGLE INJECTION AND 72 HOURS MULTIPLE INJECTION MUST NOT BE USED FOR HUMAN CONSUMPTION.; Host/pest details: CAT: [ANTIBIOTICS - ORAL, PARENTERAL]; CATTLE: [ANTIBIOTICS - ORAL, PARENTERAL]; DOG: [ANTIBIOTICS - ORAL, PARENTERAL]; HORSE: [ANTIBIOTICS - ORAL, PARENTERAL]; PIGS: [ANTIBIOTICS - ORAL, PARENTERAL]; SHEEP: [ANTIBIOTICS - ORAL, PARENTERAL]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANTIBIOTICS - ORAL, PARENTERAL]; CATTLE: [ANTIBIOTICS - ORAL, PARENTERAL]; DOG: [ANTIBIOTICS - ORAL, PARENTERAL]; HORSE: [ANTIBIOTICS - ORAL, PARENTERAL]; PIGS: [ANTIBIOTICS - ORAL, PARENTERAL]; SHEEP: [ANTIBIOTICS - ORAL, PARENTERAL]; For the treatment of infections caused by organisms susceptible to neomycin sulphate.
認証ステータス:
Stopped
承認日:
2020-07-01
情報リーフレット
WITHHOLDING PERIODS: DO
NCT
ADMINISTER
LATER THAN
30
DAYS CATTLE. SHEEP
PIGS
AND
HORSES BEFORE SLAUGHTER
FOH
HUMAN
CONSUMPTION
MlLKTAKEN
FROM
ANIMALS
WITHIN
36 HOURS SINGLE INJECTION AND
R
HOURS
MULTIPLE INJECTION MUST NOT BE USED FOR
HUMAN CONSUMPION
SUPPLY
WITHOUT
PRESCRIPTION
ILLEGAL
FOR ANIMAL TREATMENT ONLY
Neoject 200
ANTIBIOTIC
INJECTION
fuXIVE
CONSTITUENTS
EACH
ml
CONTAINS
NEOMYCIN
SULPHATE BP 200 MA
100 MI
STERILE INJECTION
NEOJECT 200 ANTIBIOTIC INJECTION
HISTORY: Neomycin was discovered in 1949 in the United States when
scientists
searched
for
an
antibiotic
which
was
effective
against
streptomycin-resistant gram-negative organisms. It was prepared from
an actinomycete later identified as streptomyces fradiae found in a
so11
sample from a farmyard in New Jersey State Agriculture College.
Neomycm raw material is manufactured by biosynthetic methods for
submerged deep-vat fermentation
usmg
streptomyces fradiae cultures,
then extracted and purified. Neomycin in
commercial
formulations
consists
of two components, Neomycins B
&
C. These are chemically
slmllar ano are both biologically active.
ACTIONS
&
SPECTRUM: Neomycin
IS
a bactencidal antibiotic with a
wide actlvlty agamst gram-positive and gram-negative organisms and
agamst a number of actmomycetes. Neomycin is active against
E.Coll,
Aerobacter and Proteus and
IS
effective against Staphylococcus Albus
and
S.
Aureus.
It
does
have
limited
activity against Streptococci.
Maximum blood levels followtng Intramuscular injection are achieved
wtthtn
one hour
with
appreciable amounts being present from four to
eight hours, hence the necessity to repeat dosage every 8-12 hours.
INDICATIONS: Neoject 200
IS
rndlcated for the treatment of infecttons
caused by
orgamsms
susceptible to Neomycin Sulphate In pneumonia,
bronchltls. pleurisy and metrltis
In
cattle, horses, sheep and
pigs.
It
IS
also
effective
agarnst
collform
ententls
in
all
species
and unnary
lnfectrons
due to coltforms, especially when other antlblottcs fall
DOSAGE: Cattle, Horses, Sheep
&
Pigs
-
The recom
完全なドキュメントを読む
製品の特徴
PRODUCT NAME: NEOJECT 200 ANTIBIOTIC INJECTION
PAGE: 1 OF 5
8
0
0
2
,
R
E
B
M
E
V
O
N
:
D
E
U
S
S
I
N
O
I
S
I
V
E
R
S
I
H
T
MATERIAL SAFETY DATA SHEET
4
4
8
8
4
2
6
9
2
1
6
+
:
E
N
O
H
P
CEVA DELVET PTY LTD
:
Y
B
D
E
U
S
S
I
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
4
4
8
8
4
2
6
9
2
1
6
+
:
E
N
O
H
P
CEVA DELVET PTY LTD
4
4
5
1
4
2
6
9
2
1
6
+
:
X
A
F
D
R
S
R
E
W
O
P
6
2
7
4
1
2
W
S
N
,
LL
I
H
N
E
V
E
S
SUBSTANCE:
Injectable preparation of neomycin sulfate.
TRADE NAME:
NEOJECT 200 ANTIBIOTIC INJECTION
PRODUCT CODE:
36693
PRODUCT USE:
Bacterial antibiotic used in cattle, horses, sheep pigs and some small animals.
CREATION DATE:
NOVEMBER, 2008
THIS REVISION ISSUED:
NOVEMBER, 2008
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as: Not classified as hazardous according to the criteria of ASCC.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code.
RISK PHRASES: Not Hazardous - No criteria found.
SAFETY PHRASES: S45, S24/25. In case of accident or if you feel unwell, contact a doctor or Poisons Information
Centre immediately (show this MSDS where possible). Avoid contact with skin and eyes.
SUSDP CLASSIFICATION: S4
ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER: None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR: Injectable liquid in 100mL sterile vials.
ODOUR: No data
MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. This is an antibiotic preparation.
Any person with a history of allergies to this class of substances should
完全なドキュメントを読む
